Search

everythinglearnresearchcommunity

for

Search:↓

Two children with lysinuric protein intolerance showed symptoms similar to lupus.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Psychosis can be an early sign of neuropsychiatric lupus, treatable with tailored medication.

Early treatment of pediatric lupus-related eye issues is crucial to prevent vision loss.

Lupus hepatitis can affect male SLE patients and is treatable with specific medications.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

Maintaining anticoagulation is crucial for patients with antiphospholipid syndrome.

A woman with lupus had hair loss and skin issues that were successfully treated with medications.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.